» Articles » PMID: 31182783

LncRNA PSORS1C3 is Regulated by Glucocorticoids and Fine-tunes OCT4 Expression in Non-pluripotent Cells

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jun 12
PMID 31182783
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

OCT4 is a transcription factor known for its regulatory roles in stemness, tumorigenesis and stress response. Considering its versatile functions, expression of OCT4 is regulated at different levels. PSORS1C3, a long non-coding RNA overlapped with OCT4, has a putative association with immune mediated diseases; however, its exact functions remained to be elucidated. Here, we demonstrated that PSORS1C3 is regulated by glucocorticoids (GC), has two endogenously active promoters, promoter 0 and 1, and two sets of transcripts, short and long variants. According to our findings, PSORS1C3 promoters behaved differently during neural differentiation of NT2 cells and glucocorticoid receptor (GR) activation. In both processes the expression pattern of short variants differed from that of long variants and was similar to OCT4 expression. Furthermore, our data revealed that PSORS1C3's promoter 0 could act as an enhancer for OCT4 in non-pluripotent cells, where its deletion caused a significant decrease in OCT4 expression. Meanwhile, during GR activation promoter 0 functioned as a negative regulator and alleviated transcription induction of OCT4 after GC treatment. Altogether, our work clarified the structure and regulation of PSORS1C3, explained its relation to immune-related disease through GR signaling and introduced it as a novel fine-tuner of OCT4 expression in non-pluripotent cells.

Citing Articles

Exploring the role of non-coding RNAs in atrial septal defect pathogenesis: A systematic review.

Amirsardari Z, Gholipour A, Khajali Z, Maleki M, Malakootian M PLoS One. 2024; 19(8):e0306576.

PMID: 39172906 PMC: 11340980. DOI: 10.1371/journal.pone.0306576.


Exposure to war and conflict: The individual and inherited epigenetic effects on health, with a focus on post-traumatic stress disorder.

Raza Z, Hussain S, Foster V, Wall J, Coffey P, Martin J Front Epidemiol. 2024; 3:1066158.

PMID: 38455905 PMC: 10910933. DOI: 10.3389/fepid.2023.1066158.


Improvements in lung function following vitamin C supplementation to pregnant smokers are associated with buccal DNA methylation at 5 years of age.

Shorey-Kendrick L, McEvoy C, Milner K, Harris J, Brownsberger J, Tepper R Clin Epigenetics. 2024; 16(1):35.

PMID: 38413986 PMC: 10900729. DOI: 10.1186/s13148-024-01644-8.


LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications.

Yang K, Tang J, Li H, Zhang H, Ding J, Li Z Mol Cell Biochem. 2023; 479(8):1969-1984.

PMID: 37639198 DOI: 10.1007/s11010-023-04832-x.


Differential Expression of Spliced Transcript Variants in Breast Cancer.

Saadat Akhtar M, Gholipour A, Moghaddam M, Oveisee M, Mowla S, Malakootian M Iran J Public Health. 2023; 52(2):427-435.

PMID: 37089151 PMC: 10113567. DOI: 10.18502/ijph.v52i2.11896.


References
1.
Nicolaides N, Galata Z, Kino T, Chrousos G, Charmandari E . The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2009; 75(1):1-12. PMC: 2813911. DOI: 10.1016/j.steroids.2009.09.002. View

2.
Coulson J . Transcriptional regulation: cancer, neurons and the REST. Curr Biol. 2005; 15(17):R665-8. DOI: 10.1016/j.cub.2005.08.032. View

3.
Pazin M . Using the ENCODE Resource for Functional Annotation of Genetic Variants. Cold Spring Harb Protoc. 2015; 2015(6):522-36. PMC: 4521767. DOI: 10.1101/pdb.top084988. View

4.
Galvin K, Shi Y . Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol. 1997; 17(7):3723-32. PMC: 232224. DOI: 10.1128/MCB.17.7.3723. View

5.
Newton R . Anti-inflammatory glucocorticoids: changing concepts. Eur J Pharmacol. 2013; 724:231-6. DOI: 10.1016/j.ejphar.2013.05.035. View